First Eagle Investment Management’s GSK GSK Stock Holding History

First Eagle Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3	Closed	-$101	–	401
2023 Q1	$101	Sell	3 -59,457	-100%	-$2.08M	﹤0.01%	395
2022 Q4	$2.09M	Buy	59,460 +9,901	+20%	+$330K	0.01%	259
2022 Q3	$1.46M	Sell	49,559 -17,451	-26%	-$661K	﹤0.01%	272
2022 Q2	$3.65M	Buy	67,010 +19,483	+41%	+$1.08M	0.01%	105
2022 Q1	$2.59M	Buy	47,527 +14,252	+43%	+$774K	0.01%	121
2021 Q4	$1.83M	Buy	33,275 +18,363	+123%	+$955K	﹤0.01%	92
2021 Q3	$712K	Buy	14,912 +5,871	+65%	+$295K	﹤0.01%	93
2021 Q2	$450K	Buy	9,041 +8,524	+1,649%	+$410K	﹤0.01%	93
2021 Q1	$23K	Buy	517 +258	+100%	+$11.7K	﹤0.01%	95
2020 Q4	$12K	Buy	+259	New	+$11.9K	﹤0.01%	93
2018 Q1	–	Sell	-1	Closed	–	–	225
2017 Q4	$0	Hold	1	–	–	﹤0.01%	341
2017 Q3	$0	Hold	1	–	–	﹤0.01%	352
2017 Q2	$0	Hold	1	–	–	﹤0.01%	334
2017 Q1	$0	Hold	1	–	–	﹤0.01%	327
2016 Q4	$0	Hold	1	–	–	﹤0.01%	343
2016 Q3	$0	Hold	1	–	–	﹤0.01%	355
2016 Q2	$0	Hold	1	–	–	﹤0.01%	361
2016 Q1	$0	Hold	1	–	–	﹤0.01%	343
2015 Q4	$0	Hold	1	–	–	﹤0.01%	337
2015 Q3	$0	Hold	1	–	–	﹤0.01%	326
2015 Q2	$0	Hold	1	–	–	﹤0.01%	319
2015 Q1	$0	Hold	1	–	–	﹤0.01%	341
2014 Q4	$0	Hold	1	–	–	﹤0.01%	345
2014 Q3	$0	Hold	1	–	–	﹤0.01%	342
2014 Q2	$0	Hold	1	–	–	﹤0.01%	353
2014 Q1	$0	Hold	1	–	–	﹤0.01%	396
2013 Q4	$0	Hold	1	–	–	﹤0.01%	379
2013 Q3	$0	Hold	1	–	–	﹤0.01%	366
2013 Q2	$0	Buy	+1	New	+$63	﹤0.01%	355

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Eagle Investment Management's GSK Position: Q2 2023 in Review

First Eagle Investment Management sold out of GSK (GSK) in Q2 2023, closing a stake of 3 shares — an estimated $101 sold.

First Eagle Investment Management first reported a position in GSK in Q2 2013 and held it in 29 quarters. The position peaked at $3.65M in Q2 2022. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

First Eagle Investment Management reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
First Eagle Investment Management sold 3 GSK shares in Q2 2023, an estimated $101.
First Eagle Investment Management first reported a position in GSK in Q2 2013 and held it in 29 quarters.
First Eagle Investment Management's GSK position peaked at $3.65M in Q2 2022.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on First Eagle Investment Management's 13F filing for Q2 2023, filed 9 Aug 2023.